Late-onset programmed cell death protein-1 inhibitor-induced pneumonitis after cessation of nivolumab or pembrolizumab in patients with advanced non-small cell lung cancer: a case series

Awareness of the immune-related adverse event of programmed cell death protein-1 (PD-1) inhibitor-induced pneumonitis is important. Herein, we report the clinical course of 3 patients suspected to have PD-1 inhibitor-induced pneumonitis after cessation of PD-1 inhibitor treatment. In case 1, a 62-ye...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimura, Hideharu, Sone, Takashi, Araya, Tomoyuki, Murata, Akari, Yamamura, Kenta, Ohkura, Noriyuki, Hara, Johsuke, Abo, Miki, Kasahara, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044496/
https://www.ncbi.nlm.nih.gov/pubmed/33889531
http://dx.doi.org/10.21037/tlcr-20-582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044496/
https://www.ncbi.nlm.nih.gov/pubmed/33889531
http://dx.doi.org/10.21037/tlcr-20-582

Ejemplares similares